Overview
- 20 inspections across 19 sites are on record.
- 3 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-09-11.
At a glance
Inspections
20
Sites
19
Observations
3
Career since
Jun 2011
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Encube Ethicals Private Limited | 11 Sep 2025 | Human Drugs | |
| SGS Analytics Switzerland AG | 8 Nov 2024 | Human Drugs | |
| Norwich Clinical Services | 27 Sep 2024 | Human Drugs | |
| AXIS Clinicals Limited | 20 Sep 2024 | Human Drugs | |
| Eurofins Amatsi Analytics | 3 Nov 2023 | Human Drugs | On file |
Sites inspected
Encube Ethicals Private LimitedKalyan, India1 insp.
SGS Analytics Switzerland AGBirsfelden, Switzerland1 insp.
Norwich Clinical ServicesBengaluru, India1 insp.
AXIS Clinicals LimitedHyderabad, India1 insp.
Eurofins Amatsi AnalyticsFontenilles, France1 insp.
Co-investigators
Investigators who share inspections with this person.
Yiying E Chen3 shared
Melkamu Getie Kebtie2 shared
Amanda Lewin2 shared
Makini Cobourne-Duval2 shared
Perry H Gambrell2 shared
Arindam Dasgupta1 shared
Mohsen Rajabi Abhari1 shared
Zhou Chen1 shared
Nicola M Fenty-Stewart1 shared
Natalie J Ayoub1 shared
Full investigator report
Get the verbatim findings behind Gopa Biswas' 3 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site